Skip to main content
Caplight Logo









Henry Meds

Henry Meds

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://henrymeds.com/

Last Round

Seed

Oct 14, 2022

Total Funding Raised

$2.2M

Company Overview

Henry Meds is a healthcare company that operates a telehealth platform offering subscription-based services for weight management, hormone replacement, and other endocrine conditions.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

telehealth weight losscompounded GLP-1compounded semaglutidecompounded tirzepatidedirect-to-consumer telehealthOzempic alternativecompounded Ozempicweight loss medicationsubscription medicationcompounding pharmacycash-pay healthcaretestosterone replacement therapyTRThormone replacement therapyHRTerectile dysfunction treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Henry Meds Comparables

Compare Henry Meds with similar companies based on industry and business-model similarity.

Henry Meds comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ivim Health
92%
Mochi Health
91%
OrderlyMeds
90%

Henry Meds Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 14, 2022

Key People

Founding team and executive leadership

Ian Gruber

Chief Operating Officer

Executive Team

Henry Meds Investors

Notable investors and investment history

Henry Meds investors
InvestorRounds
SecwaysSeed
Vye VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 14, 2024

    Grew 28% QoQ, from 318 to 406 employees.

  • Aug 31, 2024

    Grew 37% QoQ, from 283 to 387 employees.

Henry Meds Filings

Explore SEC and related filing metadata, where available.

Henry Meds filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Henry Meds's valuation, stock price, and market status.

Is Henry Meds a public or private company?

Henry Meds is a private company.

What is the current stock price of Henry Meds?

Henry Meds is a private company with no public stock price. No recent secondary market data is available.

How much is Henry Meds worth (valuation)?

Valuation information for Henry Meds is not publicly available.

Can I buy Henry Meds stock?

Henry Meds shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Henry Meds's last funding round?

Henry Meds's most recent funding round was Seed on October 14, 2022.

Who are the main investors in Henry Meds?

Key investors in Henry Meds include Secways, Vye Ventures.

Will Henry Meds IPO soon?

No public IPO plans have been announced for Henry Meds.

How can I track Henry Meds secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Henry Meds's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range156
Year Founded2022
Last FundingOct 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?